{"billNo":"202110037820000","相關附件":[{"網址":"https://ppg.ly.gov.tw/ppg/download/agenda1/02/pdf/11/01/11/LCEWA01_110111_00147.pdf","名稱":"關係文書PDF"},{"網址":"https://ppg.ly.gov.tw/ppg/download/agenda1/02/word/11/01/11/LCEWA01_110111_00147.doc","名稱":"關係文書DOC"}],"議案流程":[{"會期":"11-01-11","院會/委員會":"院會","狀態":"排入院會 (交社會福利及衛生環境委員會)","日期":["2024-04-26","2024-04-30"],"會議代碼":"院會-11-1-11"},{"會期":"11-01-11","院會/委員會":"院會","狀態":"交付審查","日期":["2024-04-26","2024-04-30"],"會議代碼":"院會-11-1-11"}],"關連議案":[],"議案名稱":"「癌症防治法第十六條條文修正草案」，請審議案。","提案單位/提案委員":"本院委員林淑芬等20人","議案狀態":"交付審查","議案類別":"法律案","提案來源":"委員提案","屆期":11,"會期":1,"meet_id":"院會-11-1-11","laws":["02565"],"mtime":"2024-07-10T22:09:38+08:00","提案人":["林淑芬","陳亭妃"],"字號":"院總第20號委員提案第11003782號","案由":"本院委員林淑芬、陳亭妃等20人，為減輕癌症病人家庭經濟負擔，提升癌症新藥可近性，建立癌症新藥獲得健保給付前的過渡型支持機制，爰擬具「癌症防治法第十六條條文修正草案」。是否有當？敬請公決。","連署人":["黃秀芳","李坤城","許智傑","黃捷","王美惠","洪申翰","林月琴","張雅琳","吳沛憶","陳培瑜","吳秉叡","鍾佳濱","蔡易餘","王正旭","沈伯洋","賴惠員","賴瑞隆","王世堅"],"對照表":[{"law_id":"02565","law_name":"癌症防治法","立法種類":"修正條文","title":"癌症防治法第十六條條文修正草案對照表","rows":[{"現行":"第十六條　國家應寬列人力與經費，確保有效推動癌症防治工作。","law_content_id":"02565:02565:2003-04-29-制定:16","說明":"一、為保障國人癌症治療新藥之可近性，爰新增本條第二項至第四項。\n\n二、第二項明定中央主管機關應設置癌症新藥多元支持基金，並明定基金來源。\n\n三、第三項明定癌症新藥多元支持基金之用途。\n\n四、第四項授權中央主管機關另定癌症新藥多元支持基金之設置、補助對象、申請及審查程序，及其他應遵行事項之辦法。","修正":"第十六條　國家應寬列人力與經費，確保有效推動癌症防治工作。\n\n中央主管機關應設置癌症新藥多元支持基金；其基金來源如下：\n\n一、政府預算撥充。\n\n二、菸品健康福利捐。\n\n三、捐贈收入。\n\n四、基金孳息收入。\n\n五、其他收入。\n\n前項基金之用途如下：\n\n一、補助全民健康保險未給付之癌症新藥費用。\n\n二、補助其他有關癌症新興治療之費用。\n\n第二項基金之設置、補助對象、申請及審查程序，及其他應遵行事項之辦法，由中央主管機關定之。"}]}],"first_time":"2024-04-26","last_time":"2024-04-30","提案編號":"20委11003782","ppg_url":"https://ppg.ly.gov.tw/ppg/bills/202110037820000/details"}